Evidence map›Paper›PMID 30704456›Full record

ArticleBMC medical genomics2019

A graph-based algorithm for estimating clonal haplotypes of tumor sample from sequencing data.

Yixuan Wang, Xuanping Zhang, Shuai Ding, Yu Geng, Jianye Liu, Zhongmeng Zhao, Rong Zhang, Xiao Xiao, Jiayin Wang

Abstract read
In one paragraph

Article in BMC medical genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yixuan WangDepartment of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China.
Xuanping ZhangDepartment of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China. zxp@mail.xjtu.edu.cn.
Shuai DingSchool of Management, Ministry of Education Key Laboratory of Process Optimization and Intelligent Decision-Making, Hefei University of Technology, Hefei, 23009, China.
Yu GengDepartment of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China.
Jianye LiuDepartment of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China.
Zhongmeng ZhaoDepartment of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China.
Rong ZhangDepartment of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China.
Xiao XiaoShaanxi Engineering Research Center of Medical and Health Big Data, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China.
Jiayin WangDepartment of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710048, China. wangjiayin@mail.xjtu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHaplotype phasing is an important step in many bioinformatics workflows. In cancer genomics, it is suggested that reconstructing the clonal haplotypes of a tumor sample could facilitate a comprehensive understanding of its clonal architecture and further provide valuable reference in clinical diagnosis and treatment. However, the sequencing data is an admixture of reads sampled from different clonal haplotypes, which complicates the computational problem by exponentially increasing the solution-space and leads the existing algorithms to an unacceptable time-/space- complexity. In addition, the evolutionary process among clonal haplotypes further weakens those algorithms by bringing indistinguishable candidate solutions.

resultsTo improve the algorithmic performance of phasing clonal haplotypes, in this article, we propose MixSubHap, which is a graph-based computational pipeline working on cancer sequencing data. To reduce the computation complexity, MixSubHap adopts three bounding strategies to limit the solution space and filter out false positive candidates. It first estimates the global clonal structure by clustering the variant allelic frequencies on sampled point mutations. This offers a priori on the number of clonal haplotypes when copy-number variations are not considered. Then, it utilizes a greedy extension algorithm to approximately find the longest linkage of the locally assembled contigs. Finally, it incorporates a read-depth stripping algorithm to filter out false linkages according to the posterior estimation of tumor purity and the estimated percentage of each sub-clone in the sample. A series of experiments are conducted to verify the performance of the proposed pipeline.

conclusionsThe results demonstrate that MixSubHap is able to identify about 90% on average of the preset clonal haplotypes under different simulation configurations. Especially, MixSubHap is robust when decreasing the mutation rates, in which cases the longest assembled contig could reach to 10kbps, while the accuracy of assigning a mutation to its haplotype still keeps more than 60% on average. MixSubHap is considered as a practical algorithm to reconstruct clonal haplotypes from cancer sequencing data. The source codes have been uploaded and maintained at https://github.com/YixuanWang1120/MixSubHap for academic use only.

Indexed as

AlgorithmsComputer GraphicsHaplotypesSequence AnalysisBase SequenceComputational BiologyHumansNeoplasmsCancer genomicsClonal haplotypeComputational pipelineHaplotype phasingSequencing data analysis

Identifiers

PMID30704456
PMCPMC6357344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.